Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other financing activities (2020 - 2023)

Historic Other financing activities for Terns Pharmaceuticals (TERN) over the last 4 years, with Q1 2023 value amounting to $344000.0.

  • Terns Pharmaceuticals' Other financing activities changed N/A to $344000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $344000.0, marking a year-over-year decrease of 1421.45%. This contributed to the annual value of $388000.0 for FY2024, which is 1279.07% up from last year.
  • As of Q1 2023, Terns Pharmaceuticals' Other financing activities stood at $344000.0.
  • Over the past 5 years, Terns Pharmaceuticals' Other financing activities peaked at $1.7 million during Q2 2021, and registered a low of $33000.0 during Q1 2020.
  • Its 4-year average for Other financing activities is $617714.3, with a median of $344000.0 in 2023.
  • Examining YoY changes over the last 5 years, Terns Pharmaceuticals' Other financing activities showed a top increase of 302424.24% in 2021 and a maximum decrease of 302424.24% in 2021.
  • Quarter analysis of 4 years shows Terns Pharmaceuticals' Other financing activities stood at $825000.0 in 2020, then soared by 104.85% to $1.7 million in 2021, then tumbled by 84.79% to $257000.0 in 2022, then skyrocketed by 33.85% to $344000.0 in 2023.
  • Its last three reported values are $344000.0 in Q1 2023, $257000.0 for Q4 2022, and $144000.0 during Q3 2022.